Novagali oculus Treatment pro Vernal Keratoconjunctivitis (VKC) Prosperitas in Phase III Tentatio
Tuesday, April 10th, 2007Israeli- Fanaticus venenum development vexillum Novagali SA, quod eram fundator in basis of research se gero per Profano. Simon Benita of Hebrew Universitas of Jerusalem, has successfully universa European Rememdium Procurator (EMEA) Phase III clinical tentatio of suus oculus treatment pro Vernal Keratoconjunctivitis (VKC)..
Partis Is
































